Penn STEM Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Penn STEM Times.

Press releases published on September 2, 2026

Sep. 2, 2026

Revamp Garage Door Company Announces New TV Commercial Debuting on WPGH-53 Morning News

Indeterminate EIN Presswire

Sep. 2, 2026

Vendilli Adds HubSpot Vet Cathy Cordova as Principal GTM Strategist

Indeterminate EIN Presswire

Sep. 2, 2026

Peel Launches New iPhone 18 Collection, Led by Super Thin 2.0 & Expanded Stealth Line

Indeterminate EIN Presswire

Sep. 2, 2026

JNJY LLC HELPS LAW FIRMS GROW WITH ACCIDENT NEWS PUBLISHING

Indeterminate EIN Presswire

Sep. 2, 2026

QCI Introduces Trip-Based Analysis for Host and Marketing Teams

Indeterminate GlobeNewswire

Sep. 2, 2026

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of August 31, 2026

Indeterminate GlobeNewswire

Sep. 2, 2026

Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 août 2026

Indeterminate GlobeNewswire

Sep. 2, 2026

New England Journal of Medicine Publishes Phase 1/2 Clinical Data on Revolution Medicines’ RASONQUE™ (daraxonrasib) in Metastatic Non-Small Cell Lung Cancer

Indeterminate GlobeNewswire

Sep. 2, 2026

Patton and alfanar Partner™ to Accelerate Secure Digital Transformation of Saudi Power Infrastructure

Indeterminate GlobeNewswire

Sep. 2, 2026

BioRestorative Therapies Announces Reverse Stock Split

Indeterminate GlobeNewswire

Sep. 2, 2026

Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 2, 2026

Zoom Appoints Former Oracle CFO Jeff Epstein to Board of Directors; Jonathan Chadwick to Retire

Indeterminate GlobeNewswire

Sep. 2, 2026

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 2, 2026

Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 2, 2026

Byrna Appoints Matt McBrady to Board of Directors

Indeterminate GlobeNewswire

Sep. 2, 2026

Supernus Pharmaceuticals to Participate in September Investor Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

SL Science Holding Limited Rings Nasdaq Bell, Capping an Active First Quarter as a Publicly Traded Company

Indeterminate GlobeNewswire

Sep. 2, 2026

Inventiva Announces Last Patient Visit in NATiV3 Phase 3 Clinical Trial of Lanifibranor in MASH

Indeterminate GlobeNewswire

Sep. 2, 2026

Inventiva annonce la dernière visite du dernier patient de l’étude clinique de Phase 3 NATiV3 évaluant le lanifibranor dans la MASH

Indeterminate GlobeNewswire

Sep. 2, 2026

Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire